BIONOMICS LIMITED
ADS · ADR · CUSIP 09063M205
5
institutional holders
-1 vs Q4 2021
399.2k
shares reported held*
$3.4mreported value*
0 new
0 added
3 reduced
1 sold out
net sold ≈ $341.5k (-40.0k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $8.53.
Trends to Q1 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2021 | 6 |
| Q1 2022 | 5 |
Biggest buyers
| None |
Biggest sellers
| Light Sky Macro LP | Reduced | -37.9k |
| Woodline Partners LP | Reduced | -1.0k |
| UBS Group AG | Reduced | -974 |
| Tower Research Capital LLC (TRC) | Sold out | -100 |
Holders, Q1 2022
| Manager | Shares | Change |
|---|---|---|
| Woodline Partners LP 0.02% of their portfolio | 160.9k $1.4m | Reduced -1.0k |
| Light Sky Macro LP 100.00% of their portfolio | 157.3k $1.3m | Reduced -37.9k |
| BVF INC/IL 0.03% of their portfolio | 81.0k $692.0k | Unchanged |
| UBS Group AG 0.00% of their portfolio | 56 $0 | Reduced -974 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |